Wuxi AppTec to invest $120m in antibody discovery and development lab
Newly private WuXi AppTec has announced plans to invest $120m in a biopharmaceutical development laboratory and clinical-scale manufacturing facility in Shanghai, China.
Archives for January 12, 2016
One by one: Continuous manufacturing gets broad support
Continuous manufacturing (CM) offers several benefits over traditional pharma manufacturing, including real-time monitoring, says expert.
Thermo Fisher to expand cellular analysis toolbelt in $1.3bn 'sensible' deal
Thermo Fisher will expand its antibody, multiplex RNA, and protein analysis tech offerings through the $1.3bn acquisition of Affymetrix.
UK pharma manufacturing output to grow in 2016 says EEF
UK pharma manufacturing output increased last year according to EEF, which says lower costs and a legacy of R&D investment will drive further growth in 2016.
Vaccine contract manufacturing market to undergo shift, says analyst
According to analysts, the vaccine contract manufacturing market is poised for growth, and change, as new players emerge in the East.
Focused R&D is key to productivity according to Deloitte
As annual projected pharmaceutical R&D returns continue to decline and companies are under increasing pressure, focus may be the defining factor.
MannKind withdraws job offer a week after Insulet's ex-CEO was set to start
Insulet CEO Duane DeSisto will no longer be taking the top job at MannKind Corporation after the inhaled insulin developer withdrew the offer.